TOXICITY OF WEEKLY LIPOSOMAL DOXORUBICIN AND PACLITAXEL IN METASTATIC BREAST CANCER (MBC)

被引：0
|
作者：
Longo, F. [1 ]
Pellegrini, P. [1 ]
Ceccarelli, F. [1 ]
Borgomastro, A. [1 ]
Comito, T. [1 ]
Basile, M. L. [1 ]
De Biasio, G. [2 ]
Girolami, M. [2 ]
Spalletta, B. [1 ]
Di Seri, M. [1 ]
机构：
[1] Univ Roma La Sapienza, Dept Expt Med & Pathol, Rome, Italy
[2] Univ Roma La Sapienza, Dept Surg 4, Rome, Italy
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：23 / 23
页数：1
相关论文
共 50 条
  • [41] Neoadjuvant chemotherapy with low dose of pegylated liposomal doxorubicin plus weekly paclitaxel in operable and locally advanced breast cancer
    Rossi, David
    Baldelli, Anna Maria
    Casadei, Virginia
    Fedeli, Stefano Luzi
    Alessandroni, Paolo
    Catalano, Vincenzo
    Giordani, Paolo
    Ceccolini, Monica
    Graziano, Francesco
    Catalano, Giuseppina
    [J]. ANTI-CANCER DRUGS, 2008, 19 (07) : 733 - 737
  • [42] Phase III trial of non-pegylated liposomal doxorubicin (M) in combination with trastuzumab (T) and paclitaxel (P) in HER2+metastatic breast cancer (MBC).
    De La Pena, Lorena
    Cortes, Javier
    Manikhas, Alexey
    Roman, Laslo
    Semiglazov, Vladimir
    Biakhov, Mikhail Yu
    Dasappa, Lokanatha
    Llombart, Antonio
    Rozencweig, Marcel
    Forenza, Salvatore
    Goldfarb, Ronald H.
    Matera, Jeri
    Azarnia, Nozar
    Hudis, Clifford
    Baselga, Jose
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [43] IMP321 and weekly paclitaxel as first-line chemo-immunotherapy for metastatic breast cancer (MBC)
    Gutierrez, Maya
    Brignone, Chrystelle
    Grygar, Caroline
    Marcu, Manon
    Triebel, Frederic
    [J]. JOURNAL OF IMMUNOTHERAPY, 2007, 30 (08) : 873 - 873
  • [44] Oral paclitaxel in the treatment of metastatic breast cancer (MBC) patients.
    Dai, Ming-Shen
    Chao, Ta-Chong
    Chiu, Chang-Fan
    Lu, Yen-Shen
    Shiah, Her-Shyongi
    Wu, Yi-Yin
    Cheng, Wei-Hong
    Chan, Wing Kai
    Hung, Tak
    Hung, Noelyn
    Cutler, David
    Kwan, Rudolf
    Kramer, Douglas
    Chao, Tsu-Yi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [45] Pegylated liposomal doxorubicin in elderly patients with metastatic breast cancer
    Minisini, Alessandro M.
    Andreetta, Claudia
    Fasola, Gianpiero
    Puglisi, Fabio
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (03) : 331 - 342
  • [46] Salvage treatment in metastatic breast cancer with weekly paclitaxel and bevacizumab
    Polyzos, Aris
    Kalbakis, Kostas
    Kentepozidis, Nikolaos
    Giassas, Stylianos
    Kalykaki, Antonia
    Vardakis, Nikolaos
    Bozionelou, Vasiliki
    Saloustros, Emmanouel
    Kontopodis, Emmanouel
    Georgoulias, Vassilis
    Mavroudis, Dimitris
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (01) : 217 - 223
  • [47] Salvage treatment in metastatic breast cancer with weekly paclitaxel and bevacizumab
    Aris Polyzos
    Kostas Kalbakis
    Nikolaos Kentepozidis
    Stylianos Giassas
    Antonia Kalykaki
    Nikolaos Vardakis
    Vasiliki Bozionelou
    Emmanouel Saloustros
    Emmanouel Kontopodis
    Vassilis Georgoulias
    Dimitris Mavroudis
    [J]. Cancer Chemotherapy and Pharmacology, 2011, 68 : 217 - 223
  • [48] Weekly administration of docetaxel and paclitaxel in metastatic or advanced breast cancer
    Eniu, A
    Palmieri, FM
    Perez, EA
    [J]. ONCOLOGIST, 2005, 10 (09): : 665 - 685
  • [49] Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas
    Italiano, Antoine
    Cioffi, Angela
    Penel, Nicolas
    Levra, Matteo Giaj
    Delcambre, Corinne
    Kalbacher, Elsa
    Chevreau, Christine
    Bertucci, Francois
    Isambert, Nicolas
    Blay, Jean-Yves
    Bui, Binh
    Antonescu, Cristina
    D'Adamo, David R.
    Maki, Robert G.
    Keohan, Mary Louise
    [J]. CANCER, 2012, 118 (13) : 3330 - 3336
  • [50] Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma
    Lyass, O
    Uziely, B
    Ben-Yosef, R
    Tzemach, D
    Heshing, NI
    Lotem, M
    Brufman, G
    Gabizon, A
    [J]. CANCER, 2000, 89 (05) : 1037 - 1047
12345